Mixed pH-Sensitive Polymeric Micelles for Combination Drug Delivery

被引:47
作者
Bae, Younsoo [1 ]
Alani, Adam W. G. [2 ]
Rockich, Nicole C. [2 ]
Lai, T. S. Z. Chung [2 ]
Kwon, Glen S. [2 ]
机构
[1] Univ Kentucky, Coll Pharm, Lexington, KY 40536 USA
[2] Univ Wisconsin, Div Pharmaceut Sci, Sch Pharm, Madison, WI 53705 USA
基金
美国国家卫生研究院;
关键词
combination chemotherapy; drug delivery; mixed micelles; pH-controlled release; polymeric micelles; TOPOISOMERASE-II; SIGNALING PATHWAYS; ANTICANCER DRUGS; BREAST-CANCER; CELL-DEATH; HSP90; TARGET; CHEMOTHERAPY; EXPRESSION; GELDANAMYCIN;
D O I
10.1007/s11095-010-0234-3
中图分类号
O6 [化学];
学科分类号
0703 ;
摘要
To prepare mixed polymeric micelles that can carry two different drugs, doxorubicin (DOX) and 17-hydroxyethylamino-17-demethoxygeldanamycin (GDM-OH), for combination cancer chemotherapy. The pH-sensitive micelles were prepared from poly(ethylene glycol)-poly(aspartate hydrazide) block copolymers to which either DOX or GDM-OH is conjugated through acid-labile hydrazone bond (individual micelles). Mixed micelles were formed not only by simply mixing two different individual micelles in aqueous solutions (aqueous mixed micelles) but also by evaporating organic solvents from the organic/aqueous mixed solvents in which two block copolymers possessing different drugs were dissolved homogeneously (organic mixed micelles). Particle size measurements, pH-dependent drug release tests, cytotoxicity assays and western blot analysis were subsequently conducted. Individual and aqueous/organic mixed micelles showed clinically relevant particle size (< 100 nm) and pH-dependent drug release patterns. Mixed polymer micelles suppress cancer cell growth effectively in a drug concentration, mixing method and schedule-dependent way. Combination chemotherapy using polymeric micelles seems to minimize a schedule-dependent change in combination drug efficacy in comparison to drug combination using DMSO formulations.
引用
收藏
页码:2421 / 2432
页数:12
相关论文
共 41 条
[1]   Polymeric micelles for the pH-dependent controlled, continuous low dose release of paclitaxel [J].
Alani, Adam W. G. ;
Bae, Younsoo ;
Rao, Deepa A. ;
Kwon, Glen S. .
BIOMATERIALS, 2010, 31 (07) :1765-1772
[2]   Selective anticancer drugs [J].
Atkins, JH ;
Gershell, LJ .
NATURE REVIEWS CANCER, 2002, 2 (09) :645-645
[3]  
Bae Y, 2005, MOL BIOSYST, V1, P242, DOI 10.1039/b500266d
[4]   Design of environment-sensitive supramolecular assemblies for intracellular drug delivery: Polymeric micelles that are responsive to intracellular pH change [J].
Bae, Y ;
Fukushima, S ;
Harada, A ;
Kataoka, K .
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2003, 42 (38) :4640-4643
[5]   Preparation and biological characterization of polymeric micelle drug carriers with intracellular pH-triggered drug release property: Tumor permeability, controlled subcellular drug distribution, and enhanced in vivo antitumor efficacy [J].
Bae, Y ;
Nishiyama, N ;
Fukushima, S ;
Koyama, H ;
Yasuhiro, M ;
Kataoka, K .
BIOCONJUGATE CHEMISTRY, 2005, 16 (01) :122-130
[6]   Mixed polymeric micelles for combination cancer chemotherapy through the concurrent delivery of multiple chemotherapeutic agents [J].
Bae, Younsoo ;
Diezi, Thomas A. ;
Zhao, Anni ;
Kwon, Glen S. .
JOURNAL OF CONTROLLED RELEASE, 2007, 122 (03) :324-330
[7]   Intelligent biosynthetic nanobiomaterials for hyperthermic combination chemotherapy and thermal drug targeting of HSP90 inhibitor geldanamycin [J].
Bae, Younsoo ;
Buresh, Rita A. ;
Williamson, Tracy P. ;
Chen, Tze-Haw Howard ;
Furgeson, Darin Y. .
JOURNAL OF CONTROLLED RELEASE, 2007, 122 (01) :16-23
[8]   Intelligent polymeric micelles from functional poly(ethylene glycol)-poly(amino acid) block copolymers [J].
Bae, Younsoo ;
Kataoka, Kazunori .
ADVANCED DRUG DELIVERY REVIEWS, 2009, 61 (10) :768-784
[9]   The topoisomerase II-Hsp90 complex: A new chemotherapeutic target? [J].
Barker, CR ;
Hamlett, J ;
Pennington, SR ;
Burrows, F ;
Lundgren, K ;
Lough, R ;
Watson, AJM ;
Jenkins, JR .
INTERNATIONAL JOURNAL OF CANCER, 2006, 118 (11) :2685-2693
[10]   Inhibition of Hsp90 acts synergistically with topoisomerase II poisons to increase the apoptotic killing of cells due to an increase in topoisomerase II mediated DNA damage [J].
Barker, CR ;
McNamara, AV ;
Rackstraw, SA ;
Nelson, DE ;
White, MR ;
Watson, AJM ;
Jenkins, JR .
NUCLEIC ACIDS RESEARCH, 2006, 34 (04) :1148-1157